Park Kye Won, Jo Sungyang, Kim Mi Sun, Choi Nari, Jeon Sang Ryong, Park Hee Kyung, Kwon Kyum-Yil, Lee Chong S, Chung Sun Ju
Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Department of Neurosurgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
J Neurol Sci. 2020 Oct 15;417:117063. doi: 10.1016/j.jns.2020.117063. Epub 2020 Jul 28.
Although dementia is a contraindication for deep brain stimulation (DBS) in patients with Parkinson's disease (PD), the concept is supported by little scientific evidence. Moreover, it is unclear whether PD with mild cognitive impairment (PD-MCI) or domain-specific cognitive impairments affect the outcome of DBS in non-demented PD patients.
To investigate the influence of baseline cognitive profiles of PD on the outcome of DBS.
Baseline cognitive levels of patients with PD who underwent DBS were classified into PD with dementia (PDD) (n = 15), PD-MCI (n = 210), and normal cognition (PD-NC) (n = 79). The impact of the cognitive level on key DBS outcome measures [mortality, nursing home admission, progression to Hoehn&Yahr (HY) stage 5 and progression to PDD] were analyzed using Cox regression models. We also investigated whether impairment of a specific cognitive domain could predict these outcomes in non-demented patients.
Patients with PDD showed a substantially higher risk of nursing home admission and progression to HY stage 5 compared with patients with PD-MCI [hazard ratio (HR) 4.20, P = .002; HR = 5.29, P < .001] and PD-NC (HR 7.50, P < .001; HR = 7.93, P < .001). MCI did not alter the prognosis in patients without dementia, but those with visuospatial impairment showed poorer outcomes for nursing home admission (P = .015), progression to HY stage 5 (P = .027) and PDD (P = .006).
Cognitive profiles may stratify the pre-operative risk and predict long-term outcomes of DBS in PD.
尽管痴呆是帕金森病(PD)患者深部脑刺激(DBS)的禁忌证,但这一概念几乎没有科学证据支持。此外,尚不清楚伴有轻度认知障碍(PD-MCI)的PD或特定领域的认知障碍是否会影响非痴呆PD患者的DBS疗效。
探讨PD患者基线认知特征对DBS疗效的影响。
将接受DBS治疗的PD患者的基线认知水平分为痴呆型PD(PDD)(n = 15)、PD-MCI(n = 210)和认知正常(PD-NC)(n = 79)。使用Cox回归模型分析认知水平对DBS关键疗效指标[死亡率、入住养老院、进展至Hoehn&Yahr(HY)5期和进展至PDD]的影响。我们还研究了特定认知领域的损害是否可以预测非痴呆患者的这些结局。
与PD-MCI患者[风险比(HR)4.20,P = 0.002;HR = 5.29,P < 0.001]和PD-NC患者(HR 7.50,P < 0.001;HR = 7.93,P < 0.001)相比,PDD患者入住养老院和进展至HY 5期的风险显著更高。MCI并未改变无痴呆患者的预后,但存在视觉空间损害的患者在入住养老院(P = 0.015)、进展至HY 5期(P = 0.027)和PDD(P = 0.006)方面预后较差。
认知特征可能对PD患者DBS的术前风险进行分层,并预测其长期疗效。